Modifi Bio
New Haven
About Modifi Bio
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drug development methods.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.1M
- Funding stage: M&A
- Last round: Seed (Oct 2023)
- Website: modifibio.com
- Phone: 2034352255
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/modifi-bio-7769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.